| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 91, 858-866, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
ME Faymonville, G Deby-Dupont, R Larbuisson, C Deby, L Bodson, R Limet and M Lamy
To study the effect of lung bypass on the production of prostaglandin E2,
prostacyclin, and thromboxane A2, we measured simultaneously arterial and
venous plasma concentrations of prostaglandin E2, 6-keto- prostaglandin F1
alpha (stable metabolite of prostacyclin), and thromboxane B2 (stable
metabolite of thromboxane A2) before, during, and after cardiopulmonary
bypass. Seventeen patients (age range 46 to 69 years) undergoing
aorta-coronary bypass grafts were investigated. The prostaglandin E2
production rose sharply immediately after the onset of bypass (baseline:
9.7 +/- 2.9 pg/ml to 85 +/- 16.6 pg/ml in venous and 87 +/- 12 pg/ml in
arterial plasma, p less than 0.03) and rapidly decreased after pulmonary
reperfusion (53 +/- 6.4 and 57 +/- 20 pg/ml, respectively, in venous and
arterial plasma at the end of bypass). The increase in prostaglandin E2 was
influenced by the heart- lung machine itself (as demonstrated by a closed
"bypass" circuit) and by lung bypass. Pulmonary metabolism of prostaglandin
E2 was maintained after bypass. The prostacyclin production rose
significantly at the beginning of bypass (154 +/- 26 pg/ml venous prebypass
level to 361 +/- 94 pg/ml after aortic clamping, p less than 0.03).
Prostacyclin decreased progressively during rewarming of the patient,
pulmonary reperfusion, and discontinuation of bypass. When prostacyclin
decreased, thromboxane B2 production rose significantly and reached peak
arterial levels when the lungs were reperfused (112 +/- 33 pg/ml prebypass
levels to 402 +/- 101 pg/ml, p less than 0.01). Except for prostaglandin
E2, there were no significant differences between arterial and venous
plasma levels of these substances. The same prostanoids were also measured
in five patients undergoing major orthopedic operations, and no significant
changes in prostanoids were observed. Our data demonstrate significant
production of prostaglandin E2 in the systemic circulation during
cardiopulmonary bypass in humans. They further indicate that lung bypass
disturbs the plasma prostaglandin/thromboxane balance.
ARTICLES
Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans
This article has been cited by other articles:
|
|
 |
|
  J. W. Hammon Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389. [Full Text]
|
|
|
|
 |
|
 S. A Hassantash, G. R Omrani, N. Givtaj, and M. Afrakhteh Pharmacological Prevention of the Deleterious Effects of Cardiopulmonary Bypass Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 218 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Arshad, V. Vijay, B. C. Floyd, B. Marks, M. R. Sarabu, M. S. Wolin, and S. A. Gupte Thromboxane Receptor Stimulation Suppresses Guanylate Cyclase-Mediated Relaxation of Radial Arteries Ann. Thorac. Surg., June 1, 2006; 81(6): 2147 - 2154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Honemann, K. Hahnenkamp, T. Podranski, D. Strumper, M. W. Hollmann, and M. E. Durieux Local Anesthetics Inhibit Thromboxane A2 Signaling in Xenopus Oocytes and Human K562 Cells Anesth. Analg., September 1, 2004; 99(3): 930 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W. Bahouth Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese Humans Endocrinology, May 1, 2004; 145(5): 2273 - 2282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Edmunds Jr. and R. W. Colman Extracorporeal Circulation: Thrombosis and Bleeding Card. Surg. Adult, January 1, 2003; 2(2003): 338 - 348. [Full Text]
|
|
|
|
|
|
P. Menasche and L. H. Edmunds Jr. Extracorporeal Circulation: The Inflammatory Response Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360. [Full Text]
|
|
|
|
|
|
M. Nagashima, Y. Imai, K. Seo, M. Terada, M. Aoki, T. Shin'oka, and M. Koide Effect of hemofiltrated whole blood pump priming on hemodynamics and respiratory function after the arterial switch operation in neonates Ann. Thorac. Surg., December 1, 2000; 70(6): 1901 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohata, Y. Sawa, K. Kadoba, T. Masai, H. Ichikawa, and H. Matsuda Effect of Cardiopulmonary Bypass Under Tepid Temperature on Inflammatory Reactions Ann. Thorac. Surg., July 1, 1997; 64(1): 124 - 128. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. M. Kirshbom, S. O. Page, M. T. Jacobs, S. S. L. Tsui, E. Bello, R. M. Ungerleider, D. A. Schwinn, and J. W. Gaynor CARDIOPULMONARY BYPASS AND CIRCULATORY ARREST INCREASE ENDOTHELIN-1 PRODUCTION AND RECEPTOR EXPRESSION IN THE LUNG J. Thorac. Cardiovasc. Surg., April 1, 1997; 113(4): 777 - 783. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. M. Reddy, K. D. Hendricks-Munoz, H. A. Rajasinghe, E. Petrossian, F. L. Hanley, and J. R. Fineman Post Cardiopulmonary Bypass Pulmonary Hypertension in Lambs With Increased Pulmonary Blood Flow: A Role for Endothelin 1 Circulation, February 18, 1997; 95(4): 1054 - 1061. [Abstract] [Full Text]
|
|
|
|
|
|
V. M. Reddy, J. R. Liddicoat, J. R. Klein, D. B. McElhinney, R. K. Wampler, and F. L. Hanley Fetal Cardiac Bypass Using an In-Line Axial Flow Pump to Minimize Extracorporeal Surface and Avoid Priming Volume Ann. Thorac. Surg., August 1, 1996; 62(2): 393 - 400. [Abstract] [Full Text]
|
|
|
|
|
|
Y. J. Gu, A. J. deVries, P. W. Boonstra, and W. van Oeveren LEUKOCYTE DEPLETION RESULTS IN IMPROVED LUNG FUNCTION AND REDUCED INFLAMMATORY RESPONSE AFTER CARDIAC SURGERY J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 494 - 500. [Abstract] [Full Text]
|
|
|
|
|
|
K. E. Wehberg, A. H. Foster, R. M. Wise, J. S. McLaughlin, and M. J. Brunner NITRIC OXIDE MEDIATES FLUID ACCUMULATION DURING CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., July 1, 1996; 112(1): 168 - 174. [Abstract] [Full Text]
|
|
|
|
|
|
P. M. Kirshbom, M. T. Jacobs, S. S. L. Tsui, L. R. DiBernardo, D. A. Schwinn, R. M. Ungerleider, and J. W. Gaynor EFFECTS OF CARDIOPULMONARY BYPASS AND CIRCULATORY ARREST ON ENDOTHELIUM-DEPENDENT VASODILATATION IN THE LUNG J. Thorac. Cardiovasc. Surg., June 1, 1996; 111(6): 1248 - 1256. [Abstract] [Full Text]
|
|
|
|
|
|
M. Friedman, S. Y. Wang, F. W. Sellke, A. Franklin, R. M. Weintraub, and R. G. Johnson Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition Ann. Thorac. Surg., March 1, 1995; 59(3): 598 - 603. [Abstract] [PDF]
|
|
|
|
|
|
W. P. Wagner, P. C. Johnson, K. A. Thompson, and G. C. Marrone Heparin-coated cardiopulmonary bypass circuits: Hemostatic alterations and postoperative blood loss Ann. Thorac. Surg., September 1, 1994; 58(3): 734 - 741. [Abstract] [PDF]
|
|
|
|
|
|
T. Shafique, F. W. Sellke, R. L. Thurer, R. M. Weintraub, and R. G. Johnson Cardiopulmonary bypass and pulmonary thromboxane generation Ann. Thorac. Surg., March 1, 1993; 55(3): 724 - 728. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Komai and S. G Haworth The effect of cardiopulmonary bypass on the lung: the injured pulmonary vascular endothelium Perfusion, January 1, 1993; 8(1): 55 - 62. [PDF]
|
|
|
|
|
|
R. J. Novick, K. R. Reid, L. Denning, J. Duplan, A. H. Menkis, and F. Neil McKenzie Prolonged preservation of canine lung allografts: The role of prostaglandins Ann. Thorac. Surg., May 1, 1991; 51(5): 853 - 859. [Abstract] [PDF]
|
|
|
|
|
|
Y. J. Gu, Y. S. Wang, B. Y. Chiang, X. D. Gao, C. X. Ye, and C. R. H. Wildevuur Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypass Ann. Thorac. Surg., April 1, 1991; 51(4): 573 - 578. [Abstract] [PDF]
|
|
|
|
 |
|
 P. J. A. van der Starre, R. S. Reneman, and H. W. Scheijgrond Ketanserin in the Treatment of Systemic Hypertension During and Following Coronary Artery Bypass Surgery Angiology, November 1, 1989; 40(11): 1001 - 1010. [Abstract] [PDF]
|
|
|
|
 |
|
 R. J. Howard, C. Crain, D. A. Franzini, C. I. Hood, and T. E. Hugli Effects of Cardiopulmonary Bypass on Pulmonary Leukostasis and Complement Activation Arch Surg, December 1, 1988; 123(12): 1496 - 1501. [Abstract] [PDF]
|
|
|
|
|
|
A. Harjula, J. C. Baldwin, and N. E. Shumway Donor Deep Hypothermia or Donor Pretreatment with Prostaglandin E1 and Single Pulmonary Artery Flush for Heart-Lung Graft Preservation: An Experimental Primate Study Ann. Thorac. Surg., November 1, 1988; 46(5): 553 - 555. [Abstract] [PDF]
|
|
|
|
|
|
W. van Oeveren, N. J. G. Jansen, B. P. Bidstrup, D. Royston, S. Westaby, H. Neuhof, and C. R. H. Wildevuur Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary Bypass Ann. Thorac. Surg., December 1, 1987; 44(6): 640 - 645. [Abstract] [PDF]
|
|
|
|
|
|
W. van Oeveren and C. Wildevuur Review article : Blood compatibility of cardiopulmonary bypass circuits Perfusion, October 1, 1987; 2(4): 237 - 244. [PDF]
|
|
|
|
|
|
P. Boonstra, F. Vermeulen, J. Leusink, E. de Nooy, A. van Zalk, J. Soons, and C. Wildevuur Platelet damage and haemolysis during bubble oxygenator perfusion with and without arterial line filter, compared to membrane oxygenator perfusion Perfusion, January 1, 1987; 2(1): 27 - 33. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
